Business Context and Reporting Period
This Form 8-K is a current report filed by PharmAthene, Inc. (not Altimmune, Inc.) on November 12, 2009. The filing announces the company's financial and operational results for the quarter ended September 30, 2009. The detailed results are contained in a press release furnished as Exhibit 99.1, which is not included in the provided text.
Key Financial Metrics
The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being available in the attached press release (Exhibit 99.1), which is not part of the input content.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms that results for the quarter ended September 30, 2009, were announced.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, or contingencies. It includes a standard disclaimer stating that the information in this report and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name is PharmAthene, Inc., as the request metadata incorrectly listed Altimmune, Inc.
- Locate and review Exhibit 99.1 (the press release dated November 12, 2009) to obtain actual financial figures for the quarter ended September 30, 2009.
- Confirm the company's status and operational updates directly from the press release, as the 8-K body contains no operational details.